# Mark Krailo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-krailo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,286 |
| Field | Sarcoma Diagnosis and Treatment |
| h-index | 95 |
| i10-index | 311 |
| Last Known Institution | University of Southern California |
| OpenAlex ID | https://openalex.org/A5090325707 |
| ORCID iD | https://orcid.org/0000-0002-7608-0698 |
| Works | 531 |

## Researcher papers

- [Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort](https://scholariq.org/papers/survival-and-prognosis-with-osteosarcoma-outcomes-in-more-than-2000-patients-in/)
- [Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial](https://scholariq.org/papers/comparison-of-mapie-versus-map-in-patients-with-a-poor-response-to-preoperative/)
- [Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration](https://scholariq.org/papers/risk-stratified-staging-in-paediatric-hepatoblastoma-a-unified-analysis-from-the/)
- [Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial](https://scholariq.org/papers/methotrexate-doxorubicin-and-cisplatin-map-plus-maintenance-pegylated-interferon/)
- [EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment](https://scholariq.org/papers/euramos-1-an-international-randomised-study-for-osteosarcoma-results-from-pre/)
- [Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study](https://scholariq.org/papers/dose-intensified-compared-with-standard-chemotherapy-for-nonmetastatic-ewing/)
- [The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model](https://scholariq.org/papers/the-children-s-hepatic-tumors-international-collaboration-chic-novel-global-rare/)
- [Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/effects-of-sodium-thiosulfate-versus-observation-on-development-of-cisplatin/)

## Researcher topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Testicular diseases and treatments](https://scholariq.org/topics/testicular-diseases-and-treatments-2/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Researcher university

- [University of Southern California](https://scholariq.org/institutions/university-of-southern-california/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.